Multiple signal transducers and activators of transcription are induced by EBV LMP-1. (Q40551263)

21 September 2017

Multiple signal transducers and activators of transcription are induced by EBV LMP-1. (English)

1 reference

21 September 2017

Luwen Zhang

1

1 reference

21 September 2017

Ke Hong

series ordinal

2

1 reference

21 September 2017

Jun Zhang

series ordinal

3

1 reference

21 September 2017

Joseph S Pagano

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

21 September 2017

12

1 reference

inferred from page(s)

published in

Virology

1 reference

21 September 2017

323

1 reference

21 September 2017

1

1 reference

21 September 2017

141-152

1 reference

A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Establishment in continuous culture of a new type of lymphocyte from a “burkitt-like” malignant lymphoma (line d.g.-75)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Mechanism of action of a novel latent membrane protein-1 dominant negative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

The role of STATs in transcriptional control and their impact on cellular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

The growing family of interferon regulatory factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus: the first human tumor virus and its role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr viral latency and cell immortalization as targets for antisense oligomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus regulates STAT1 through latent membrane protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

IRF family of transcription factors as regulators of host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.007

7 January 2021

10.1016/J.VIROL.2004.03.007

Identifiers

DOI

1 reference

21 September 2017

1 reference